From January 2010 to August 2018, Gregory Gerber, MD, 58, repeatedly prescribed controlled substances — including fentanyl, oxycodone and oxymorphone — without a legitimate medical purpose, the Justice Department said in a March 14 news release.
Dr. Gerber also received $175,000 from writing 835 prescriptions for Subsys, a branded formulation of fentanyl manufactured by Insys Therapeutics, between 2013 and 2016.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.